Professional Overview
Dan is a seasoned executive currently serving as the Head of Innovation & New Commercial Partnerships and Head of Sandoz Innovation Lab Germany, located in Munich, Bavaria, Germany. His key expertise areas include innovation, commercial partnerships, and pharmaceuticals, with a strong industry focus on healthcare and life sciences.
Experience Summary
Current Role
Dan's current position involves leading innovation and new commercial partnerships at Sandoz, a prominent pharmaceutical company. His key responsibilities include driving innovation, forging new commercial partnerships, and overseeing the Sandoz Innovation Lab in Germany. Notably, his current role impacts the healthcare industry by introducing innovative solutions and collaborating with external partners to enhance patient outcomes.
Career Progression
Dan's career progression is marked by notable roles that demonstrate his growth and expertise. Previously, he served as the eHealth Lead, where he explored digital health solutions, and as the Head of Oncology, overseeing strategies for oncology products. Earlier in his career, Dan worked as a Consultant and Associate Consultant at Bain & Company, gaining valuable experience in management consulting. These roles have contributed to his ability to navigate complex healthcare issues, lead cross-functional teams, and drive business growth.
Areas of Expertise
Dan's expertise spans several areas, including:
- Industry-specific skills: Pharmaceutical industry knowledge, healthcare innovation, and commercial partnerships.
- Technical competencies: Digital health solutions, data analysis, and market research.
- Leadership and management capabilities: Strategic planning, team leadership, and change management.
Professional Impact
Dan has been involved in several notable projects and initiatives throughout his career, although specific details are not provided. His contributions to the healthcare industry are significant, with a focus on innovation, partnerships, and patient-centric solutions. While measurable achievements are not available, his current and past roles indicate a strong capacity for driving business growth, leading innovation, and collaborating with external partners.
Conclusion
Dan's professional trajectory is characterized by a steady progression towards leadership roles in innovation and healthcare. Currently, his focus is on driving innovation and forging new commercial partnerships at Sandoz. His value proposition lies in his unique blend of industry knowledge, technical skills, and leadership capabilities, making him a valuable asset in the pharmaceutical and healthcare sectors.